US Patent 8008012 Biomarkers downregulated in prostate cancer
All edits
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+398 characters)
Article
Patent abstract
Biomarkers are identified by analyzing gene expression data using support vector machines (SVM), recursive feature elimination (RFE) and/or linear ridge regression classifiers to rank genes according to their ability to separate prostate cancer from normal tissue. Proteins expressed by identified genes are detected in patient samples to screen, predict and monitor prostate cancer.
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08008012 Biomarkers downregulated in prostate cancer US Patent 8008012 Biomarkers downregulated in prostate cancer
Infobox
Patent Number
0800801200
Patent Number
800801200
Edits on 5 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
080080120
Date of Patent
August 30, 2011
0Patent Application Number
122429120
Date Filed
September 30, 2008
0Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
080080120
Date of Patent
August 30, 2011
0Patent Application Number
122429120
Date Filed
September 30, 2008
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 08008012 Biomarkers downregulated in prostate cancer
Infobox
Is a
Patent jurisdiction
Patent number
08008012
Date of patent
August 30, 2011
Patent application number
12242912
Date Filed
September 30, 2008
Patent primary examiner
Find more entities like US Patent 8008012 Biomarkers downregulated in prostate cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
